12/05/2014 - 11:39

Admedus raises $8m for CardioCel

12/05/2014 - 11:39

Bookmark

Save articles for future reference.

Biotech company Admedus has completed an oversubscribed $8 million share placement as it looks to push marketing for its CardioCel regenerative tissue product in Europe and the US.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options